Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-024144
Filing Date
2021-06-16
Accepted
2021-06-16 16:24:10
Documents
1
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3978
  Complete submission text file 0000899243-21-024144.txt   5440
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Issuer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CAMBRIDGE MA 02139
Business Address
Cunningham, Richard Anthony (Reporting) CIK: 0001624783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38169 | Film No.: 211021793